Nasdaq:US$20.09 (-0.08) | HKEX:HK$31.30 (-0.75) | AIM:£3.24 (+0)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 18 Jun 2007

Chi-Med locks-in property gain and protects low cost R&D structure through acquisition of Shanghai facility

1 items
a070618